Drug Class
CTLA-4 immune checkpoint inhibitor
Type
ingredient
Active Ingredient
ipilimumab
📋Overview
Ipilimumab is a type of immunotherapy drug known as a monoclonal antibody. It works by targeting and blocking a protein called CTLA-4, which helps regulate the immune system. By inhibiting this protein, ipilimumab can enhance the body's immune response against cancer cells. It is most commonly associated with the treatment of certain types of cancers, particularly melanoma.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Ipilimumab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.